Masaki Hayama

Nishinomiya-hama, JP 
Nishinomiya-hama, JP 

Overview

Masaki Hayama practices practicing medicine in Nishinomiya-hama, Japan.

His clinical expertise encompasses Hereditary Hemorrhagic Telangiectasia, Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Telangiectasia, and Endoscopy.

He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Nishinomiya-hama, Japan
Other Locations
Suita, Japan
Department Of Otorhinolaryngology Head And Neck Surgery, Osaka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
Enrollment Status: Completed
Publish Date: July 22, 2026
Intervention Type: Drug
Study Drugs: Mepolizumab, Standard of Care
Study Phase: Phase 3

29 Total Publications

A Case of Infectious Mononucleosis With Peritonsillar Abscess in a Middle-Aged Patient.
A Case of Infectious Mononucleosis With Peritonsillar Abscess in a Middle-Aged Patient.
Journal: Cureus
Published: October 30, 2025

Frequently Asked Questions about Masaki Hayama

Is Masaki Hayama a top-rated expert for Hereditary Hemorrhagic Telangiectasia?

MediFind is an objective health platform that identifies experts based on real-world data. Masaki Hayama is classified as an Experienced expert for Hereditary Hemorrhagic Telangiectasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Masaki Hayama participate in research or clinical trials?

Yes. Masaki Hayama has published 29 articles and abstracts on conditions like Hereditary Hemorrhagic Telangiectasia. You can view a list of Masaki Hayama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hayama's expertise for a condition
ConditionClose
        View All 19 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile